PlainPharmaWatch

CMS Open Payments · Program Year 2024

Roche Diabetes Care, Inc.

Roche Diabetes Care, Inc. reported $505,278.07 across General Payments, Research, and Ownership to 18 physicians and teaching hospitals across 60 transactions.

See the rankings → How this is sourced
$505.3K
All-tracks total
60
Transactions
18
Recipients
+$2.9K
General Payments vs PY2023

Roche Diabetes Care, Inc. reported $505,278.07 across all CMS Open Payments tracks (General + Research + Ownership) to 18 physicians and teaching hospitals in Program Year 2024 - ranking #760 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $9,064.34, averaging $28.1K per recipient.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the publisher.

CMS Sunshine Act warrant

Manufacturer roche-diabetes-care-inc Roche Diabetes Care, Inc.

$505.3K · #760/1,925 · 0.0% industry · PY2024

  • TOT $505.3K
  • RANK #760
  • SHARE 0.0%
  • TXN 60
  • RCP 18
  • CAT 2
  • GEN $9.1K
  • ΔGEN +$2.9K
  • TOP1 8.6%
  • PY 2024

Volume peers

Nearest volume peer: Epimed International, Inc ($506.9K)

Central Indiana URS Consumab…$507.6KEpimed International, Inc$506.9KRoche Diabetes Care, Inc. (t…$505.3KInternational Rehabilitative…$502.5KInsight Medical Systems, Inc.$500.6K
All-tracks payment totals near Roche Diabetes Care, Inc. (CMS Open Payments PY2024)

Roche Diabetes Care, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →

Release-over-release change

General Payments changed from PY2023 to PY2024

Roche Diabetes Care, Inc.'s CMS-reported General Payments increased by $2.9K (+46.1%) from PY2023 to PY2024.

How this year-over-year comparison is scoped

The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.

CMS source labels for this exact identifier: PY2022: ROCHE DIABETES CARE, INC.PY2023: ROCHE DIABETES CARE, INC.PY2024: ROCHE DIABETES CARE, INC.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.

Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.

General Payments: PY2023 vs PY2024

Annual CMS-reported totals for this company, not an all-category Open Payments total

PY2023$6.2KPY2024$9.1K
PY2023
$6,202.39
PY2024
$9,064.34

What the Data Shows for Roche Diabetes Care, Inc.

$505,278.07: that is what Roche Diabetes Care, Inc. reported in payments to 18 physicians and teaching hospitals during Program Year 2024, spread across 60 transactions ($8.4K per transaction, $28.1K per recipient). The company sits at rank #760 of 1,925, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

The 2-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Consulting Fee" at $8.7K, accounting for 95.5% of this company's General Payments and 15 transactions.

General Payment Breakdown by Type

Across 2 types of general payments, Roche Diabetes Care, Inc.'s largest category was "Consulting Fee" at $8.7K - 95.5% of General Payments.

How Roche Diabetes Care, Inc. divides its payments

Ranked by total dollars reported per category

1. Consulting Fee$8.7K2. Food and Beverage$404.34
Payment Type Amount Transactions
Consulting Fee $8.7K 15
Food and Beverage $404.34 3

Recipient Concentration in General Payments

The five largest recipient relationships account for $3,885.00 (42.9%) of $9,064.34 in this company's General Payments records across 18 recipients.

General Payments scope note

Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Roche Diabetes Care, Inc.

The five named recipients with the highest reported General Payments from this company

Yevgeniy Kantor$777.00Melissa Katz$777.00Alina Gouller$777.00Chithranjan Nath$777.00Alan Dresner$777.00
  1. 1

    Yevgeniy Kantor

    $777.00 across 1 reported transactions

  2. 2

    Melissa Katz

    $777.00 across 1 reported transactions

  3. 3

    Alina Gouller

    $777.00 across 1 reported transactions

  4. 4

    Chithranjan Nath

    $777.00 across 1 reported transactions

  5. 5

    Alan Dresner

    $777.00 across 1 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Similarly Concentrated Companies

Companies whose General Payments are spread across recipients about as (un)evenly as Roche Diabetes Care, Inc.'s, measured by the same HHI concentration index above, not by payment size.

What HHI 2,500 means here

2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Roche Diabetes Care, Inc..

Keystone Dental Inc.

HHI 673

TheracosBio, LLC

HHI 674

EvoEndo, Inc

HHI 667

Nexus Medical Technologies Llc

HHI 667

Companies with Similar Payment Volumes

Open a profile or compare a similar company's CMS-reported payment pattern with Roche Diabetes Care, Inc..

Showing 6 of 1,924 companies with CMS-reported payment data.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Roche Diabetes Care, Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.